Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_4
2
67%
Ph phase_3
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Terminated1
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (33.3%)
Phase 42 (66.7%)

Trials by Status

terminated133%
recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingphase_4

A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems

NCT05599126
completedphase_4

Treatment of Sleep Disturbances in Trauma-affected Refugees

NCT02761161
terminatedphase_3

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567

Clinical Trials (3)

Showing 3 of 3 trials
NCT05599126Phase 4

A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems

Recruiting
NCT02761161Phase 4

Treatment of Sleep Disturbances in Trauma-affected Refugees

Completed
NCT02374567Phase 3

Pharmacovigilance in Gerontopsychiatric Patients

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3